News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area


8/11/2010 8:12:15 AM

TAMPA, Fla.--(BUSINESS WIRE)--Xcelience, a leader in early drug contract development, has expanded formulation development and manufacturing capabilities to include a Piccola B10 Minipress. This 10-station table top rotary tablet press enables clients to make an early assessment of how the developed process and formula will perform in production, which can shorten development time and lead to early identification and resolution of potential formulation issues. The ability to cost-effectively produce small batch sizes in the experimental area while obtaining all of the necessary processing parameters is an additional advantage.

Read at BioSpace.com

comments powered by Disqus
Xcelience
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES